Biora Therapeutics, Inc. Share-based Payment Arrangement, Expense
Biora Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $1.28 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-11-14
- Biora Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $1.28M, a 87.84% decline year-over-year.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $1.57M, a 21.90% decline year-over-year.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $1.54M, a 35.44% decline year-over-year.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-12-31 was $1.55M, a 28.62% decline year-over-year.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $16.48M, a 111.11% increase from fiscal 2022.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $7.80M, a 42.43% decline from fiscal 2021.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $13.56M, a 27.07% increase from fiscal 2020.
- Biora Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $10.67M, a 349.18% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $1.28M 10-Q · filed 2024-11-14 | $2.85M derived: sum of 2 quarters · filed 2024-11-14 | $4.39M 10-Q · filed 2024-11-14 | $5.94M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2024-06-30 | $1.57M 10-Q · filed 2024-08-12 | $3.11M 10-Q · filed 2024-08-12 | $4.66M derived: sum of 3 quarters · filed 2024-08-12 | $15.19M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2024-03-31 | $1.54M 10-Q · filed 2024-05-15 | $3.08M derived: sum of 2 quarters · filed 2024-05-15 | $13.62M derived: sum of 3 quarters · filed 2024-11-14 | $15.63M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $12.08M derived: sum of 2 quarters · filed 2024-11-14 | $14.09M derived: sum of 3 quarters · filed 2024-11-14 | $16.48M 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $10.53M 10-Q · filed 2024-11-14 | $12.54M derived: sum of 2 quarters · filed 2024-11-14 | $14.93M 10-Q · filed 2024-11-14 | $17.09M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $2.01M 10-Q · filed 2024-08-12 | $4.40M 10-Q · filed 2024-08-12 | $6.56M derived: sum of 3 quarters · filed 2024-08-12 | $8.95M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $2.38M 10-Q · filed 2023-05-15 | $4.55M derived: sum of 2 quarters · filed 2024-04-01 | $6.93M derived: sum of 3 quarters · filed 2024-05-15 | $8.38M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.55M derived: sum of 2 quarters · filed 2024-05-15 | $6.00M derived: sum of 3 quarters · filed 2024-05-15 | $7.80M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $2.38M 10-Q · filed 2024-05-15 | $2.14M 10-Q · filed 2022-11-14 | $3.83M derived: sum of 2 quarters · filed 2024-05-15 | $5.64M 10-Q · filed 2023-11-13 | $8.47M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-06-30 | $1.45M 10-Q · filed 2023-08-14 | $3.50M 10-Q · filed 2023-08-14 | $6.08M derived: sum of 3 quarters · filed 2023-08-14 | $9.96M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $2.05M 10-Q · filed 2023-05-15 | $4.64M derived: sum of 2 quarters · filed 2023-05-15 | $8.51M derived: sum of 3 quarters · filed 2023-05-15 | $12.98M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $6.46M derived: sum of 2 quarters · filed 2023-03-30 | $10.93M derived: sum of 3 quarters · filed 2023-03-30 | $13.56M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $3.87M 10-Q · filed 2022-11-14 | $8.34M derived: sum of 2 quarters · filed 2022-11-14 | $10.97M 10-Q · filed 2022-11-14 | $13.19M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $4.47M 10-Q · filed 2022-08-15 | $7.10M 10-Q · filed 2022-08-15 | $9.31M derived: sum of 3 quarters · filed 2022-08-15 | $12.69M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $2.63M 10-Q · filed 2022-05-10 | $4.84M derived: sum of 2 quarters · filed 2022-05-10 | $8.22M derived: sum of 3 quarters · filed 2022-05-10 | $11.24M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $5.59M derived: sum of 2 quarters · filed 2022-03-28 | $8.61M derived: sum of 3 quarters · filed 2022-03-28 | $10.67M 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $3.37M 10-Q · filed 2021-11-10 | $6.40M derived: sum of 2 quarters · filed 2021-11-10 | $8.46M 10-Q · filed 2021-11-10 | $9.05M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $3.02M 10-Q · filed 2021-08-12 | $5.08M 10-Q · filed 2021-08-12 | $5.67M derived: sum of 3 quarters · filed 2021-08-12 | $6.30M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $2.06M 10-Q · filed 2021-05-13 | $2.65M derived: sum of 2 quarters · filed 2021-05-13 | $3.28M derived: sum of 3 quarters · filed 2021-05-13 | $3.88M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-01-31 | $900.00K 10-K · filed 2022-03-28 | |||||
| 2019-12-31 | $592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.22M derived: sum of 2 quarters · filed 2021-03-18 | $1.82M derived: sum of 3 quarters · filed 2021-03-18 | $2.38M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $631.00K 10-Q · filed 2020-11-09 | $1.23M derived: sum of 2 quarters · filed 2020-11-09 | $1.78M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $597.00K 10-Q · filed 2020-08-14 | $1.15M 10-Q · filed 2020-08-14 |